NCT05457348

Brief Summary

Cataract surgery by phacoemulsification is the most commonly performed procedure in Pakistan. Cataract surgery aims for visual rehabilitation and freedom from all kinds of eyewear. Pre-operative corneal astigmatism greater than 1.0 Diopter is reported in 42% preoperatively and 58%postoperatively after implanting a monofocal intraocular lens(IOL). Visual acuity tended to worsen postoperatively with increased astigmatism4. Different treatment modalities are used to reduce astigmatism, like toric IOL. Limbal relaxing incision, actuate keratotomy, intrastromal rings, Lasik and femtosecond laser. Most of these modalities are expensive, so they cannot be afforded by the patients as Pakistan is a low-income country with a per capita income of US$1,562 (160th worldwide)

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 14, 2022

Completed
16 days until next milestone

Study Start

First participant enrolled

July 30, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2023

Completed
Last Updated

July 14, 2022

Status Verified

July 1, 2022

Enrollment Period

5 months

First QC Date

July 11, 2022

Last Update Submit

July 11, 2022

Conditions

Keywords

Astigmatism. phacoemulsification, corneal incision

Outcome Measures

Primary Outcomes (1)

  • Reduction in Astigmatism

    Postoperative reduction in astigmatism after phacoemulsification.

    Patients will be assessed at first postoperative day then after one month , three months and six months.

Study Arms (2)

Group A:experimental group

EXPERIMENTAL

those who receive planned incisions

Procedure: Planned incisions during phacoemulsification

Group B:Controlled group

ACTIVE COMPARATOR

the patients who were operated by conventional phacoemulsification

Procedure: Planned incisions during phacoemulsification

Interventions

Planned three (one 2.8 mm and two 2.0mm) on the or near to steep meridian will be performed in the experimental group during phacoemulsification

Group A:experimental groupGroup B:Controlled group

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • \. Previous ocular surgery. 2. previous ocular trauma. 3. Pre-existing ocular disease. 4. High intraocular pressure (IOP) 5. Corneal opacity. 6. Strabismus 7. Amblyopia 8. Diabetes mellitus 9. Irregular astigmatism.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Suleman Roshan Medical College Hospital

Tando Adam, Sindh, 68050, Pakistan

Location

Related Publications (6)

  • GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1.

  • Dineen B, Bourne RR, Jadoon Z, Shah SP, Khan MA, Foster A, Gilbert CE, Khan MD; Pakistan National Eye Survey Study Group. Causes of blindness and visual impairment in Pakistan. The Pakistan national blindness and visual impairment survey. Br J Ophthalmol. 2007 Aug;91(8):1005-10. doi: 10.1136/bjo.2006.108035. Epub 2007 Jan 17.

  • Liu YC, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts. Lancet. 2017 Aug 5;390(10094):600-612. doi: 10.1016/S0140-6736(17)30544-5. Epub 2017 Feb 25.

  • Day AC, Dhariwal M, Keith MS, Ender F, Perez Vives C, Miglio C, Zou L, Anderson DF. Distribution of preoperative and postoperative astigmatism in a large population of patients undergoing cataract surgery in the UK. Br J Ophthalmol. 2019 Jul;103(7):993-1000. doi: 10.1136/bjophthalmol-2018-312025. Epub 2018 Sep 6.

  • Ren Y, Fang X, Fang A, Wang L, Jhanji V, Gong X. Phacoemulsification With 3.0 and 2.0 mm Opposite Clear Corneal Incisions for Correction of Corneal Astigmatism. Cornea. 2019 Sep;38(9):1105-1110. doi: 10.1097/ICO.0000000000001915.

  • What is current GDP of Pakistan?. Paid for articles.com. naeemofficial3; Jun 19, 2022

    RESULT

Related Links

Study Officials

  • Jamshad Ahmed, FCPS

    Suleman Roshan Medical College

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jamshad Ahmed, FCPS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patient will be selected and randomized into two groups after obtaining informed consent. patient will not know about the intervention
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients will be randomized into experimental and controlled groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 11, 2022

First Posted

July 14, 2022

Study Start

July 30, 2022

Primary Completion

December 30, 2022

Study Completion

March 2, 2023

Last Updated

July 14, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will share

the clinical study report will be shared with all participants if they desire. the study will be published in a journal. it will be available to all participants and the research community.

Shared Documents
CSR
Time Frame
after 6 months
Access Criteria
contact with principal investigator

Locations